These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3114361)

  • 1. [Action of Parlodel on the preovulatory peak of estrogens and the ovulatory response of patients with abnormal ovulation and normal blood prolactin].
    Hedon B; Mares P; Cristol P; Laffargue F; Viala JL
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(4):499-506. PubMed ID: 3114361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine response in normoprolactinemic patients with polycystic ovary disease: a preliminary report.
    Seibel MM; Oskowitz S; Kamrava M; Taymor ML
    Obstet Gynecol; 1984 Aug; 64(2):213-9. PubMed ID: 6234484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
    de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
    Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinaemia and female infertility.
    Godó G
    Acta Med Hung; 1984; 41(4):185-93. PubMed ID: 6440115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
    Ellenbogen A; David H; Libal Y; Ballas S
    Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME; Alborzi S; Jahromi BN
    Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bromocriptine administration during the follicular phase of the oestrous cycle on prolactin and gonadotrophin secretion and follicular dynamics in merino monovular ewes.
    Picazo RA; González De Bulnes A; Gómez Brunet A; del Campo A; Granados B; Tresguerres J; López Sebastián A
    J Reprod Fertil; 2000 Sep; 120(1):177-86. PubMed ID: 11006160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of octamethylcyclotetrasiloxane (D4) on the luteinizing hormone (LH) surge and levels of various reproductive hormones in female Sprague-Dawley rats.
    Quinn AL; Dalu A; Meeker LS; Jean PA; Meeks RG; Crissman JW; Gallavan RH; Plotzke KP
    Reprod Toxicol; 2007 Jun; 23(4):532-40. PubMed ID: 17418525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of the ovulation date in stimulated cycles with Clostilbegyt].
    Seifert B; Kaltwasser P; Watzek H; Seliger E; Schöneich C; Nickel I
    Zentralbl Gynakol; 1987; 109(17):1059-66. PubMed ID: 3120438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of perphenazine and bromocriptine on follicular dynamics and endocrine profiles in anestrous pony mares.
    Bennett-Wimbush K; Loch WE; Plata-Madrid H; Evans T
    Theriogenology; 1998 Mar; 49(4):717-33. PubMed ID: 10732080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovulation induction with bromocryptin].
    Coelingh Bennink HJ
    Ned Tijdschr Geneeskd; 1978 Nov; 122(47):1831-40. PubMed ID: 714193
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
    Rea N; Bove F; Gentile A; Parmeggiani U
    Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin antagonist-induced lowering of prolactin secretion does not affect the pattern of pulsatile secretion of follicle-stimulating hormone and luteinizing hormone in the bitch.
    Beijerink NJ; Kooistra HS; Dieleman SJ; Okkens AC
    Reproduction; 2004 Aug; 128(2):181-8. PubMed ID: 15280557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian follicular and luteal physiology.
    Channing CP; Schaerf FW; Anderson LD; Tsafriri A
    Int Rev Physiol; 1980; 22():117-201. PubMed ID: 6248477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma LH-HCG, 17 -estradiol, estrone and progesterone monitoring around ovulation and subsequent nidation.
    Thomas K; De Hertogh R; Pizarro M; Van Exter C; Ferin J
    Int J Fertil; 1973; 18(2):65-73. PubMed ID: 4353919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME; Alborzi S; Namavar Jahromi B
    Arch Gynecol Obstet; 2004 Jan; 269(2):125-9. PubMed ID: 14648180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
    Mitwally MF; Casper RF
    J Soc Gynecol Investig; 2004 Sep; 11(6):406-15. PubMed ID: 15350255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.